Trial of Rucaparib in Patients With Metastatic Hormone-Sensitive Prostate Cancer Harboring Germline DNA Repair Gene Mutations
Clinical trial NCT03413995 · COMPLETED
Trial details
- NCT number
- NCT03413995
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-10
- Primary completion
- 2023-11-08
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.